The administration of the long-acting GLP-1R agonist exendin-4 (Ex-4) reduced brain damage, protected dopaminergic neurons against degeneration, and improved motor function in a MPTP mouse model of Parkinson’s disease [101]. The gene discussed is GLP1R; the disease is Parkinson disease.